Shopping Cart 0
Cart Subtotal
AED 0

PT Kalbe Farma Tbk (KLBF) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

PT Kalbe Farma Tbk (Kalbe) provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. Its product portfolio comprises branded and unbranded generic drugs, nutritional products, supplements and over-the-counter (OTC) drugs, energy drinks and other preventive products. Kalbe is also involved in marketing and trading of medical devices and provides distribution and logistics solutions for pharmaceuticals products in Indonesia. It has overseas branches and representative offices in ASEAN countries, Nigeria, and South Africa. The company serves hospitals, pharmacies and drug stores across Indonesia. Kalbe is headquartered in Jakarta, Indonesia.

PT Kalbe Farma Tbk (KLBF)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Kalbe Farma and Genexine Form Joint Venture 11

Licensing Agreements 12

Stemedica Cell Technologies Enters Into Licensing Agreement With PT Kalbe Farma 12

Acquisition 13

Kalbe Farma Plans To Acquire Health Food Company For USD 41.2 Million 13

PT Kalbe Farma Tbk-Key Competitors 14

PT Kalbe Farma Tbk-Key Employees 15

PT Kalbe Farma Tbk-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Joint Venture 18

Recent Developments 19

Strategy And Business Planning 19

Feb 27, 2018: Kalbe Inaugurated Drugs Ingredients and Biological Products Factory 19

Government and Public Interest 21

May 03, 2018: Kalbe Supports Downstream-ing of Research in Indonesia 21

Other Significant Developments 23

Jan 18, 2017: Kalbe Develops Biosimilar Factory 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Key Facts, 2017 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PT Kalbe Farma Tbk, Deals By Therapy Area, 2012 to YTD 2018 8

PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Kalbe Farma and Genexine Form Joint Venture 11

Stemedica Cell Technologies Enters Into Licensing Agreement With PT Kalbe Farma 12

Kalbe Farma Plans To Acquire Health Food Company For USD 41.2 Million 13

PT Kalbe Farma Tbk, Key Competitors 14

PT Kalbe Farma Tbk, Key Employees 15

PT Kalbe Farma Tbk, Other Locations 16

PT Kalbe Farma Tbk, Subsidiaries 17

PT Kalbe Farma Tbk, Joint Venture 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

PT Kalbe Farma Tbk, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

PT Kalbe Farma Tbk (Kalbe) provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. Its product portfolio comprises branded and unbranded generic drugs, nutritional products, supplements and over-the-counter (OTC) drugs, energy drinks and other preventive products. Kalbe is also involved in marketing and trading of medical devices and provides distribution and logistics solutions for pharmaceuticals products in Indonesia. It has overseas branches and representative offices in ASEAN countries, Nigeria, and South Africa. The company serves hospitals, pharmacies and drug stores across Indonesia. Kalbe is headquartered in Jakarta, Indonesia.

PT Kalbe Farma Tbk (KLBF)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Kalbe Farma and Genexine Form Joint Venture 11

Licensing Agreements 12

Stemedica Cell Technologies Enters Into Licensing Agreement With PT Kalbe Farma 12

Acquisition 13

Kalbe Farma Plans To Acquire Health Food Company For USD 41.2 Million 13

PT Kalbe Farma Tbk-Key Competitors 14

PT Kalbe Farma Tbk-Key Employees 15

PT Kalbe Farma Tbk-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Joint Venture 18

Recent Developments 19

Strategy And Business Planning 19

Feb 27, 2018: Kalbe Inaugurated Drugs Ingredients and Biological Products Factory 19

Government and Public Interest 21

May 03, 2018: Kalbe Supports Downstream-ing of Research in Indonesia 21

Other Significant Developments 23

Jan 18, 2017: Kalbe Develops Biosimilar Factory 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Key Facts, 2017 2

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PT Kalbe Farma Tbk, Deals By Therapy Area, 2012 to YTD 2018 8

PT Kalbe Farma Tbk, Medical Devices Deals, 2012 to YTD 2018 9

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Kalbe Farma and Genexine Form Joint Venture 11

Stemedica Cell Technologies Enters Into Licensing Agreement With PT Kalbe Farma 12

Kalbe Farma Plans To Acquire Health Food Company For USD 41.2 Million 13

PT Kalbe Farma Tbk, Key Competitors 14

PT Kalbe Farma Tbk, Key Employees 15

PT Kalbe Farma Tbk, Other Locations 16

PT Kalbe Farma Tbk, Subsidiaries 17

PT Kalbe Farma Tbk, Joint Venture 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

PT Kalbe Farma Tbk, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.